当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第36期
编号:13262853
DNAzymes针对Ezrin mRNA的反义技术靶点筛选及验证(4)
http://www.100md.com 2018年12月25日 《中国医药导报》 2018年第36期
     [14] Yu Y,Khan J,Khanna C,et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators Nat Med,2004,10:175-181.

    [15] Maus MK,Hanna DL,Stephens CL,et al. Distinct gene expression profiles of proximal and distal colorectal cancer:implications for cytotoxic and targeted therapy . Pharmacogenomics J,2015,15:354-362.doi:10.1038/tpj.2014.73.

    [16] Pilsl M,Crucifix C,Papai G,et al. Structure of the initiation-competent RNA polymerase I and its implication for transcription . Nat Commun,2016,7:12126.doi:10.1038/ncomms12126.

    [17] Glouzon JS,Ouangraoua A. aliFreeFold:an alignment-free approach to predict secondary structure from homologous RNA sequences . Bioinformatics,2018,34:i70-i78.doi:10.1093/bioinformatics/bty234.

    [18] Zhu Y,Xie Z,Li Y,et al. Research on folding diersity in statistical learning methods for RNA secondary structure prediction . Int J Biol Sci,2018,14:872-882.doi:10.7150/ijbs.24595.

    [19] Zhao JJ,Lemke G. Rules for ribozymes . Mol Cell Neurosci,1998,11:92-97.

    (收稿日期:2018-06-05 本文編辑:任 念), http://www.100md.com(潘辉龙 张国如 王晋 吴兴源)
上一页1 2 3 4